中華民國血液病學會 - 血液疾病研究及治療

107年3月24日(六)14:00:00

自行前往

Time	Program	Speaker
14:00 ~ 14:30	Registration
14:30 ~ 15:15	Tailoring front-line therapy in diffuse large B-cell lymphoma: who should we treat differently? ABC vs. GCB type? Employ an immunomodulatory agent in combination with R-CHOP? Maintenance therapy? How about CD30? Double hit vs. double expressor?	台大醫院柯博升醫師
	Discussion
15:15 ~ 16:00	How to treat the relapsed/refractory large B-cell lymphoma Role of transplant? Role of monoclonal antibodies? Other new agents?	成大醫院李欣學醫師
	Discussion
16:00 ~ 16:10	Break time
16:10 ~ 16:55	Making a correct diagnosis of primary mediastinal lymphoma Hodgkin’s lymphoma, grey zone lymphoma, primary mediastinal B cell lymphoma	奇美醫院莊世松醫師
	Discussion
16:55 ~ 17:40	Secondary CNS involvement in diffuse large B-cell lymphoma Defining high-risk patients Optimization of prophylaxis strategies	和信醫院譚傳德醫師
	Discussion
會後備有餐盒

Chairman: 陳彩雲醫師、王銘崇醫師
Email: hst.wg.register@gmail.com